Evidence map›Paper›PMID 42432679›Full record

Observational studyRespiratory research2026

Timely management of COPD exacerbations is associated with limited acute deterioration and early recovery: a prospective observational study.

Rainer Gloeckl, Klaus Kenn, Daniela Kroll, Tessa Schneeberger, Inga Jarosch, Michael Wittenberg, Wolfgang Hitzl, Jing Claussen, Paul Jones, Claus F Vogelmeier and 1 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04140097 (Predictors of Acute Exacerbation in Patients With COPD - an Observational Study), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04140097 active not recruitingnot on this map

Predictors of Acute Exacerbation in Patients With COPD - an Observational Study (PACE Trial)

TypeobservationalSponsorSchön Klinik Berchtesgadener LandRan2020 to 2026Enrolled355ConditionsChronic Obstructive Pulmonary Disease, COPD, COPD Exacerbation, COPD Exacerbation AcuteArmsProspective monitoring of a large variety of parameters
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rainer GloecklInstitute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany.ORCID http://orcid.org/0000-0002-2741-2748
Klaus KennPhilipps-University Marburg, German Center for Lung Research (DZL) Universities of Giessen and Marburg Lung Center (UGMLC), Marburg, Germany.
Daniela KrollInstitute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany.
Tessa SchneebergerInstitute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany.
Inga JaroschInstitute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany.
Michael WittenbergCoordinating Center for Clinical Trials of the Philipps-University of Marburg, Marburg, Germany.
Wolfgang HitzlDepartment of Ophthalmology and Optometry, Paracelsus Medical University Salzburg, Salzburg, Austria.
Jing ClaussenMedical Affairs, GlaxoSmithKline, Munich, Germany.
Paul JonesResearch and Development, GlaxoSmithKline, London, UK.
Claus F VogelmeierDepartment of Medicine, Pulmonary and Critical Care Medicine, German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.
Rembert KoczullaInstitute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany. koczulla@med.uni-marburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute exacerbations of COPD (AECOPDs) are critical events often associated with prolonged and incomplete recovery. Early recognition and prompt treatment of AECOPDs, which is rarely achieved in routine outpatient care, may influence the acute course and recovery trajectory. This study aimed to characterize the clinical course and recovery trajectory of AECOPDs detected early and treated immediately.In this prospective, observational study, COPD patients were enrolled in a closely supervised, 4-week, inpatient pulmonary rehabilitation (PR) program. Patients who developed a pulmonologist-confirmed AECOPD during PR received same-day guideline-based therapy with systemic corticosteroids and/or antibiotics. Clinical, inflammation (C-reactive protein [CRP]), lung function (forced expiratory volume in 1 s [FEV₁]), and patient-reported outcomes (COPD Assessment Test [CAT]) were assessed at PR admission (pre-AECOPD), AECOPD day 1, day 5, and post-AECOPD (PR discharge). Functional performance outcomes, including 6-minute walk distance (6MWD) and muscle strength (quadriceps and handgrip), were also assessed at baseline and post-AECOPD.Among 355 patients undergoing inpatient PR, 57 (16%) developed an AECOPD and were included in the analysis. At AECOPD onset (day 1), CRP increased significantly to 20.8 ± 41.8 mg/L (p = 0.032) and FEV₁ declined by 113 ± 220 mL (p < 0.001) compared to pre-AECOPD at baseline, while CAT scores showed no significant changes (p = 0.41). By day 5, CRP and FEV₁ were no longer significantly different from baseline. At PR discharge which occurred 13 ± 8 days after AECOPD onset, CAT scores were significantly better (23.6 ± 7.2 vs. 21.6 ± 7.8; p < 0.01), 6MWD increased (294 ± 105 m to 313 ± 126 m; p < 0.001), and quadriceps and handgrip strength improved (all p < 0.05) compared to pre-AECOPD baseline levels. No severe adverse events beyond the AECOPD occurred.In this observational cohort, episodes of AECOPD detected and treated on the day of onset during inpatient PR were characterized by short-term deterioration, normalization of inflammatory and lung function parameters within days, and subsequent improvements in patient-reported outcomes and functional performance. These findings suggest that early recognition, immediate treatment, and continued adapted physical activity may be associated with better short-term recovery trajectories following an AECOPD.Clinical trial registration ClinicalTrials.gov identifier: NCT04140097.

Indexed as

Disease ProgressionPulmonary Disease, Chronic ObstructiveRecovery of FunctionAgedFemaleForced Expiratory VolumeHumansMaleMiddle AgedProspective StudiesTime FactorsTreatment OutcomeAcute exacerbation (AECOPD)Chronic obstructive pulmonary diseaseClinical courseDisease managementEarly recognitionPatient-reported outcomes (PROs)Prospective studyPulmonary rehabilitationRecovery trajectorySymptom burden

Identifiers

PMID42432679
PMCPMC13355348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.